Latest News - Dementia & Cognitive Disorders

Monday, February 05, 2018 | Dementia & Cognitive Disorders

Caregiving for Dementia Innovation Challenge Award Winners Announced

AARP Services Inc and United Healthcare announced 2 winners in their Caregiving for Dementia Innovation Challenge out of 254 entries from 34 countries. The goal of the challenge was to identify and cr…

Read the full story

Wednesday, January 31, 2018 | Dementia & Cognitive Disorders

Innovative Drug Combination Addresses Neuroinflammatory Response and Amyloid-Beta Accumulation Associated with Alzheimer's Disease

AZTherapies, Inc., an advanced clinical stage pharmaceutical company developing breakthrough treatments for neurologic diseases associated with neuroinflammation and neurodegeneration, announced publi…

Read the full story

Tuesday, January 30, 2018 | Dementia & Cognitive Disorders

The National Institutes of Health Launches "Accelerating Medicines Partnership Parkinson's Disease" to Advance Treatment Research

As part of their Accelerating Medicines Partnership (AMP) initiative, which aims to foster collaboration among government, biopharmaceutical, life science, and non-profit organizations to advance medi…

Read the full story

Tuesday, January 16, 2018 | Dementia & Cognitive Disorders, Movement Disorders

The Generational Technology Gap May Be Closing—Even in Patients with Dementia

Senior Helpers, a provider of in-home services for seniors who wish to remain in their homes despite age-related illnesses and mobility challenges including dementia, Alzheimer’s disease, and Pa…

Read the full story

Tuesday, October 24, 2017 | Dementia & Cognitive Disorders, FDA Approval/Clearance, Phase 3/4 Trials, Research and Publications

FDA Fast-Tracks Alzheon’s Anti-Amyloid Alzheimer’s Agent

The FDA has granted Fast Track designation to Alzheon, Inc.’s investigational anti-amyloid drug ALZ-801 for the treatment of Alzheimer’s disease (AD). Using a precision medicine approach, …

Read the full story

Monday, October 02, 2017 | Dementia & Cognitive Disorders

US Postal Service Issues Alzheimer’s Disease Semipostal Stamps

New stamps for Alzheimer’s disease awareness are coming soon from the US Postal Service. Under its semipostal discretionary program, the Postal Service will issue five stamps over a 10-year peri…

Read the full story

Monday, September 11, 2017 | Dementia & Cognitive Disorders, Research and Publications

Blood Test Shown to Accurately Identify Alzheimer’s Disease

A blood test may help identify and diagnose Alzheimer’s disease. In a study published in Proceedings of the National Academy of Sciences of the United States of America, researchers used attenua…

Read the full story

Thursday, August 31, 2017 | Dementia & Cognitive Disorders, Research and Publications

Study: Women and Men with APOE Epsilon 4 Gene at Equal Risk for Alzheimer’s Disease

Although women with the APOE e3/e4 genotype have been thought to be at greater risk for Alzheimer’s disease, new research suggests that men and women between 55 and 85 years of age with the geno…

Read the full story

Monday, July 17, 2017 | Dementia & Cognitive Disorders

AAIC 2017: Electronic Self-Administered Test Performs Similarly to Pen-and-Paper Version in Detecting MCI and Early Dementias

Findings presented at the Alzheimer’s Association International Conference in London indicate that the self-administered eSAGE (BrainTest Inc.) test performs similar to its validated pen-an…

Read the full story

Monday, July 17, 2017 | Dementia & Cognitive Disorders, Research and Publications

AAIC 2017: Healthy Diets Tied to Decreased Likelihood of Cognitive Impairment In Older Individuals

The benefits of a healthy diet may extend to cognitive health, according to findings presented at the Alzheimer’s Association International Conference in London. Among nearly 6,000 older adults …

Read the full story

Thursday, July 06, 2017 | Dementia & Cognitive Disorders, Research and Publications, Sleep

Sleep Disturbances Linked to Alzheimer’s Disease

Poor sleep may be a sign that otherwise healthy individuals may have an increased risk of developing Alzheimer’s disease later in life over those who do not have sleep problems, according to a s…

Read the full story

Tuesday, June 27, 2017 | Dementia & Cognitive Disorders

Phase 3 Results Suggest Promise of Investigational Alzheimer’s Agent in Mild Disease

New Phase 3 findings published in the Journal of the Prevention of Alzheimer’s Disease show that Alzheon’s investigational agent tramiprosate (ALZ-801) may offer cognitive and functional b…

Read the full story

Tuesday, May 30, 2017 | Dementia & Cognitive Disorders, Movement Disorders, Research and Publications

Neurodegenerative Diseases Linked by Abnormal Proteins Causing Similar Damage to Brain Cells

Abnormal proteins found in Alzheimer's disease, Parkinson's disease, and Huntington's disease share a similar ability to cause damage when they invade brain cells, according to recently pu…

Read the full story

Thursday, April 06, 2017 | Dementia & Cognitive Disorders

B. Smith and Husband Dan Gasby to Receive American Brain Foundation’s PLINA Award

B. Smith and her husband Dan Gasby are the 2017 recipients of the American Brain Foundation’s Public Leadership in Neurology Award (PLINA). Smith is a celebrity chef, restaurateur, supermodel, a…

Read the full story

Tuesday, March 28, 2017 | Dementia & Cognitive Disorders, Research and Publications

New Evidence Suggests Potential for Blood-Based Alzheimer’s Biomarker

Plasma neurofilament light (NFL) may represent a blood-based, non-invasive biomarker in Alzheimer’s disease (AD), according to new findings published in the JAMA Neurology (March 27, 2017). In a…

Read the full story
Load More